SCHEMBL22818357

SCHEMBL22818357

c1ccc(-c2ccc(-c3cc4c(oc5cccc(N(c6ccccc6)c6ccccc6-c6ccccc6)c54)c4ccccc34)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.38
▸ CDC14B O60729 1/20 0.32
▸ CDC14A Q9UNH5 1/20 0.32
▸ GGPS1 O95749 1/20 0.31
▸ CYP1A1 P04798 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP1B1 Q16678 1/20 0.31
▸ PLA2G2A P14555 2/20 0.31
▸ PLA2G4A P47712 2/20 0.31
▸ PRKDC P78527 1/20 0.30
▸ CDK1 P06493 1/20 0.30
▸ CCNB1 P14635 1/20 0.30
▸ GSK3B P49841 1/20 0.30
▸ CDK5 Q00535 1/20 0.30
▸ CDK5R1 Q15078 1/20 0.30
▸ CRHR1 P34998 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22817669 1.00 ALOX5 (0.38) ALOX5CDC14BCDC14AGGPS1CYP1A1
SCHEMBL22817988 1.00 ALOX5 (0.38) ALOX5CDC14BCDC14AGGPS1CYP1A1
SCHEMBL22817960 0.98 ALOX5 (0.38) ALOX5CDC14BCDC14AGGPS1CYP1A1
SCHEMBL22818196 0.98 ALOX5 (0.38) ALOX5CDC14BCDC14AGGPS1CYP1A1
SCHEMBL22817658 0.98 ALOX5 (0.38) ALOX5CDC14BCDC14AGGPS1CYP1A1
SCHEMBL22817931 0.98 ALOX5 (0.38) ALOX5CDC14BCDC14AGGPS1CYP1A1
SCHEMBL22817685 0.98 ALOX5 (0.38) ALOX5CDC14BCDC14AGGPS1CYP1A1
SCHEMBL22817703 0.98 ALOX5 (0.38) ALOX5CDC14BCDC14AGGPS1CYP1A1
SCHEMBL22817636 0.97 ALOX5 (0.36) ALOX5CDC14BCDC14AGGPS1CYP1A1
SCHEMBL22818351 0.96 ALOX5 (0.38) ALOX5CDC14BCDC14AGGPS1PLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same LT MATERIALS CO., LTD. (KR) 2023-11-07 — — US disclosed
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same LT MATERIALS CO., LTD. (KR) 2023-11-07 — — US disclosed
EP-3757095-A2 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LT Materials Co., Ltd. (KR) 2020-12-30 — — EP disclosed
US-20200403157-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LT MATERIALS CO., LTD. (KR) 2020-12-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same CRY1, CRY2, PER2 ALOX5 1385/4885CDC14B 589/4885CDC14A 484/4885
US-20200403157-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CRY1, CRY2, PER2 ALOX5 1385/4885CDC14B 589/4885CDC14A 484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback